Atlas Trials

Sotagliflozin Bioequivalence Study

Clinical trial NCT03211195 · COMPLETED

Trial details

NCT number
NCT03211195
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2017-06-29
Primary completion
2017-08-22
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.